Table 2.

Major pharmacokinetic parameters [19], [30], [42], [49]–52].

Parameter	Tmax(h)	Cmax(ng/ml)	AUC(0–24 h)(ng/h/ml)	Ref.
25-OCH3-PPD	2.25 ± 2.47	7.18 ± 3.39	26.65 ± 7.11	[30]
25-OCH3-PPD-phospholipid complexes	2.10 ± 0.55	28.07 ± 19.52	97.24 ± 40.17	[30]
Quercetin (103)	0.50 ± 0.07	0.67 ± 0.08	2.04 ± 0.38	[42]
Quercetin-phospholipid complexes (103)	0.75 ± 0.10	1.58 ± 0.11	8.12 ± 0.95	[42]
Quercetin	1.21	179.21	1368.26	[19]
Quercetin-phospholipid complexes	1.02	724.89	3321.05	[19]
Kaempferol	6.32	180.23	1139.59	[19]
Kaempferol-phospholipid complexes	5.83	323.56	2228.21	[19]
Isorhamnetin	7.21	195.96	1153.66	[19]
Isorhamnetin-phospholipid complexes	4.32	672.29	2722.37	[19]
Luteolin	2.5 ± 0.75	3410 ± 910	10,420 ± 2350	[49]
luteolin–phospholipid complexes	2 ± 0.63	9770 ± 1250	55,790 ± 5760	[49]
Berberine	0.5	66.01 ± 15.03	384.45 ± 108.62	[50]
berberine-phospholipid complexes	2	219.67 ± 6.02	1169.19 ± 93.75	[50]
Oleanolic acid (OA)	0.313 ± 0.12	59.5 ± 10.64	259.6 ± 22.98	[51]
Solidified OA-phospholipid complexes	0.46 ± 0.001	78.7 ± 10.18	360.6 ± 19.13	[51]
Rosuvastatin	1.94 ± 0.89	183.95*103± 4.56*103	671.56*103± 5.64*103	[52]
Rosuvastatin–phospholipid complexes	1.41 ± 0.95	674.17*103± 1.24*103	2018.59*103± 3.79*103	[52]